Merrimack completes enrollment for Phase II arthritis trial
The randomized, double-blind, placebo-controlled, Phase II study is being conducted at 20 centers throughout the US. The objective of this study is to examine the safety and efficacy
Biointron Biological has launched RushData, a new platform to support the process of antibody discovery for pharmaceutical and biotechnology companies employing AI and machine learning (ML).